Skip to content
Disclosery

Northpond Ventures, LLC

Follow

13F filer, CIK 1911245, Bethesda, MD

Northpond Ventures, LLC reported $21,017,577 across 3 holdings for the quarter ended 2023-12-31, in a 13F-HR filed 2024-02-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-24-023717

Period
2023-12-31
Reported value
$21M
Holdings
3
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q4 2023

Share positions as resolved from 13F-HR 0001104659-24-023717, largest first. % of portfolio is the value over $21,017,577, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
VIGIL NEUROSCIENCE INCVIGIL NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 4,214,498 shares; 2023Q1: 4,214,498 shares; 2023Q2: 4,214,498 shares; 2023Q3: 4,214,498 shares; 2023Q4: 4,214,498 shares 4,214,498$14.2M67.78%0
CODEX DNA INCCODEX DNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 9,844,130 shares; 2023Q1: 9,844,130 shares; 2023Q2: 9,844,130 shares; 2023Q3: 9,844,130 shares; 2023Q4: 9,844,130 shares 9,844,130$3.93M18.69%0
CADLCANDEL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 1,935,215 shares; 2023Q1: 1,935,215 shares; 2023Q2: 1,935,215 shares; 2023Q3: 1,935,215 shares; 2023Q4: 1,935,215 shares 1,935,215$2.84M13.54%0Timeline

How Q4 2023 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-24-023717 base2024-02-14acceptance time not in the bulk data set